Gestational trophoblastic disease: Molecular and genetic studies

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 43, Issue 1, 1998, Pages 87-97

  Fisher, Rosemary A ^a   Newlands, Edward S ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Genetic imprinting; Molecular genetics; Trophoblastic neoplasms

Indexed keywords

CHORIOCARCINOMA; CHROMOSOME ANALYSIS; CONFERENCE PAPER; DNA POLYMORPHISM; FLOW CYTOMETRY; GENOME IMPRINTING; HYDATIDIFORM MOLE; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TROPHOBLASTIC DISEASE;

EID: 0031908035     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (125)

1. Ostor A: "God's first cancer and man's first cure": Milestones in gestational trophoblastic disease. ASCP Rev Pathol 1996;1:165-178
2. Park WW: The occurrence of sex chromatin in chorionepitheliomas and hydatidiform moles. J Pathol Bact 1957;74: 197-206
3. Kajii T, Ohama K: Androgenetic origin of hydatidiform mole. Nature 1977;268:633-634
4. Wake N, Takagi N, Sasaki M: Androgenesis as a cause of hydatidiform mole. J Natl Cancer Inst 1978;60:51-57
5. Vassilakos P, Kajii T: Hydatidiform mole: Two entities. Lancet 1976;1:259
6. Vassilakos P, Riotton G, Kajii T: Hydatidiform mole: Two entities. A morphological and cytogenetic study with some clinical considerations. Am J Obstet Gynecol 1977,127: 167-170
7. Szulman AE, Surti U: The syndromes of hydatidiform mole: I. Cytogenetic and morphologic correlations. Am J Obstet Gynecol 1978;131:665-671
8. Szulman AE, Surti U: The syndromes of hydatidiform mole: II. Morphologic evolution of the complete and partial mole. Am J Obstet Gynecol 1978;132:20-27
9. Lawler SD, Fisher RA, Pickthall VJ, et al: Genetic studies on hydatidiform moles. I. The origin of partial moles. Cancer Genet Cytogenet 1982;5:309-320
10. Jacobs PA, Szulman AE, Funkhouser J, et al: Human triploidy: Relationship between parental origin of the additional haploid complement and development of partial hydatidiform mole. Ann Hum Genet 1982;46:223-231
11. Wake N, Seki T, Fujita H, et al: Malignant potential of homozygous and heterozygous complete moles. Cancer Res 1984;44:1226-1230
12. Yang YH, Kwak HM, Park TK, et al: Comparative cytogenetic and clinicopathologic studies on gestational trophoblastic neoplasia, especially hydatidiform mole. Yonsei Med J 1986;27:250-260
13. Makino S, Sasaki MS, Fukuschima T: Cytological studies of tumours: XLI. Chromosomal instability in human chorionic lesions. Okajimas Fol Anat Jpn 1965;40:439-465
14. Wake N, Tanaka K-I, Chapman V, et al: Chromosomes and cellular origin of choriocarcinoma. Cancer Res 1981;41: 3137-3143
15. Sasaki S, Katayama PK, Roesler M, et al: Cytogenetic analysis of choriocarcinoma cell lines. Acta Obstet Gynaecol Jpn 1982;34:2253-2256
16. Sekiya S, Shirotake S, Kaiho T, et al: A newly established human gestational choriocarcinoma cell line and its characterization. Gynecol Oncol 1983;15:413-421
17. Okabe T, Sasaki N, Matsuzaki M, et al: Establishment and characterization of a new human functional cell line from a choriocarcinoma. Cancer Res 1983;43:4920-4926
18. Sheppard DM, Fisher RA, Lawler SD: Karyotypic analysis and chromosome polymorphisms in four choriocarcinoma cell lines. Cancer Genet Cytogenet 1985;16:251-259
19. Lawler S, Fisher RA: Genetic aspects of gestational trophoblastic rumors. In Trophoblastic Diseases. Edited by K Ichinoe. Tokyo, Igaku-Shoin, 1986, pp 23-33
20. Bettio D, Giardino D, Simoni G: Cytogenetic abnormalities detected by direct analysis in a case of choriocarcinoma. Cancer Genet Cytogenet 1993;68:149-151
21. Rodriguez E, Melamed J, Reuter V, et al: Chromosomal abnormalities in choriocarcinoma of the female. Cancer Genet Cytogenet 1995;80:9-12
22. Bagshawe KD, Lawler SD: Choriocarcinoma. In Cancer Epidemiology and Prevention. Edited by D Schottenfeld, JF Fraumeni. Philadelphia, WB Saunders,1982, pp 909-924
23. Bagshawe KD, Dent J, Webb J: Hydatidiform mole in England and Wales 1973-83. Lancet 1986;2:673-677
24. Bagshawe KD, Lawler SD, Paradinas FJ, et al: Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole. Lancet 1990;335:1074-1076
25. Lawler SD, Fisher RA, Dent J: A prospective study of hydatidiform mole. Am J Obstet Gynecol 1991;164:1270-1277
26. Rice LW, Berkowitz RS, Lage JM, et al: Persistent gestational trophoblastic tumor after partial hydatidiform mole. Gynecol Oncol 1990;36:358-362
27. Paradinas FJ: The histological diagnosis of hydatidiform moles. Curr Diagnostic Pathol 1994;1:24-31
28. Paradinas FJ, Browne P, Fisher RA, et al: A clinical, histopathological and flow cytometric study of 149 complete moles, 146 partial moles and 107 non-molar hydropic abortions. Histopathology 1996;28:101-109
29. Fisher RA, Lawler SD, Ormerod MG, et al: Flow cytometry used to distinguish between complete and partial hydatidiform moles. Placenta 1987;8:249-256
30. Hemming JD, Quirke P, Womack C, et al: Diagnosis of molar pregnancy and persistent trophoblastic disease by flow cytometry. J Clin Pathol 1987;40:615-620
31. Lage JM, Driscoll SG, Yavner DL, et al: Hydatidiform moles: Application of flow cytometry in diagnosis. Am J Clin Pathol 1988;89:596-600
32. Fukunaga M, Ushigome S, Fukunaga M, et al: Methods in pathology: Application of flow cytometry in diagnosis of hydatidiform moles. Mod Pathol 1993;6:353-359
33. Tommerup N, Vejerslev LO: Identification of triploidy by DA/DAPI staining of trophoblastic interphase nuclei. Placenta 1985;6:363-367
34. van de Kaa CA, Hanselaar AGJM, Hopman AHN, et al: DNA cytometric and interphase cytogenetic analyses of paraffin-embedded hydatidiform moles and hydropic abortions. J Pathol 1993;170:229-238
35. Lage JM, Weinberg DS, Yavner DL, et al: The biology of tetraploid hydatidiform moles: histopathology, cytogenetics and flow cytometry. Hum Pathol 1989;20:419-425
36. Kajii T: The road to diploid androgenesis. Jpn J Hum Genet 1986;31:61-71
37. Lawler SD, Pickthall VJ, Fisher RA, et al: Genetic studies of complete and partial hydatidiform moles. Lancet 1979;2:58
38. Jacobs PA, Wilson CM, Sprenkle JA, et al: Mechanism of origin of complete hydatidiform moles. Nature 1980;286: 714-716
39. Lawler SD, Povey S, Fisher RA, et al: Genetic studies on hydatidiform moles: II. The origin of complete moles. Ann Hum Genet 1982;46:209-222
40. Surti U, Szulman AE, O'Brien S: Complete (classic) hydatidiform mole with 46,XY karyotype of paternal origin. Hum Genet 1979;51:153-155
41. Ohama K, Kajii T, Okamoto E, et al: Dispermic origin of XY hydatidiform moles. Nature 1981;29:551-552
42. Fisher RA, Lawler SD: Heterozygous complete hydatidiform moles: Do they have a worse prognosis than homozygous complete moles? Lancet 1984;2:51
43. Fisher RA, Povey S, Jeffreys AJ, et al: Frequency of heterozygous complete hydatidiform moles, estimated by locus-specific minisatellite and Y chromosome-specific probes. Hum Genet 1989;82:259-263
44. Kovaks BW, Shahbahrami B, Tast DE, et al: Molecular genetic analysis of complete hydatidiform moles. Cancer Genet Cytogenet 1991;54:143-152
45. Kajii T, Kurashige H, Ohama K, et al: XY and XX complete moles: Clinical and morphologic correlations, Am J Obstet Gynecol 1984;150:57-64
46. Wong Z, Wilson V, Jeffreys AJ, et al: Cloning a selected fragment from a human DNA "fingerprint": Isolation of an extremely polymorphic minisatellite. Nuc Acids Res 1986;14:4605-4616
47. Wong Z, Wilson V, Patel I, et al: Characterisation of a panel of highly variable minisatellites cloned from human DNA. Ann Hum Genet 1987;51:269-288
48. Armour JAL, Povey S, Jeremiah S, et al: Systematic cloning of human minisatellites from ordered arrays of charomid libraries. Genomics 1990;8:501-512
49. Takahashi H, Kanazawa K, Ikarashi T, et al: Discrepancy in the diagnoses of hydatidiform mole by macroscopic findings and the deoxyribonucleic acid fingerprint method. Am J Obstet Gynecol 1990;163:112-113
50. Cho S, Kim SJ: Genetic study of hydatidiform moles by restriction fragment length polymorphisms (RFLPs) analysis. J Korean Med Sci 1993;8:446-452
51. Azuma C, Saji F, Takemura M, et al: Triplet pregnancy involving complete hydatidiform mole and two fetuses: Genetic analysis by deoxyribonucleic acid fingerprint. Am J Obstet Gynecol 1992;166:664-667
52. Hsu CC, McConnell J, Ko TM, et al: Twin pregnancy consisting of a complete hydatidiform mole and a fetus: genetic origin determined by DNA typing. Am J Obstet Gynecol 1993;100:867-869
53. Hoshi K, Morimura Y, Azuma C, et al: A case of quadruplet pregnancy containing complete mole and three fetuses. Am J Obstet Gynecol 1994;170:1372-1373
54. Wallace DC, Surti U, Adams CW, et al: Complete moles have paternal chromosomes but maternal mitochondrial DNA. Hum Genet 1982;61:145-147
55. Edwards YH, Jeremiah SJ, McMillan SL, et al: Complete hydatidiform moles combine maternal mitochondria with a paternal nuclear genome. Ann Hum Genet 1984;48:119-127
56. Azuma C, Saji F, Tokugawa Y, et al: Application of gene amplification by polymerase chain reaction to genetic analysis of molar mitochondrial DNA: The detection of anuclear empty ovum as the cause of complete mole. Gynecol Oncol 1991;40:29-33
57. van Blerkom J, Henry G: Cytogenetic analysis of living oocytes: Cellular basis and developmental consequences of perturbations in chromosomal organization and complement. Hum Reprod 1988;3:777-790
58. Fukuyama R, Takata M, Kudoh J, et al: DNA diagnosis of hydatidiform mole using the polymerase chain reaction. Hum Genet 1991;87:216-218
59. Fisher RA, Newlands ES: Rapid diagnosis and classification of hydatidiform moles using the polymerase chain reaction. Am J Obstet Gynecol 1993;168:563-569
60. Lane SA, Taylor GR, Ozols B, et al: Diagnosis of complete molar pregnancy by microsatellites in archival material. J Clin Pathol 1993;46:346-348
61. Fujita N, Tamura S, Shimizu N, et al: Genetic analysis of hydatidiform mole and non-molar abortion using the polymerase chain reaction method. Acta Obstet Gynecol Scand 1994;73:719-725
62. Osada H, Iitsuka Y, Matsui H, et al: A complete hydatidiform mole coexisting with a normal fetus was confirmed by variable number tandem repeat (VNTR) polymorphism analysis using polymerase chain reaction. Gynecol Oncol 1995;56:90-93
63. Weber JL, May PE: Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 1989;44:388-396
64. Edwards MC, Clemens PR, Tristan M, et al: Pentanucleotide repeat length polymorphism at the human CD4 locus. Nuc Acids Res 1991;19:4791
65. Polymeropoulos MH, Xiao H, Merril CR: Tetranucleotide repeat polymorphism at the human myelin basic protein gene (MBP). Hum Mol Genet 1992;1:658
66. Fisher RA, Soteriou B, Meredith L, et al: Previous hydatidiform mole identified as the causative pregnancy of choriocarcinoma following birth of normal twins. Int J Gynecol Cancer 1995;5:64-70
67. Fisher RA, Paradinas FJ, Soteriou BA, et al: Diploid hydatidiform moles with fetal red blood cells in molar villi: 2. Genetics. J Pathol 1997;181:189-195
68. Weber JL, Kwitek AE, May PE: Dinucleotide repeat polymorphisms at the D7S435 and D7S440 loci. Nuc Acids Res 1990;18:4039
69. Polymeropoulos MH, Xiao H, Rath DS, et al: Tetranucleotide repeat polymorphism at the human tyrosine hydroxylase gene (TH). Nuc Acids Res 1991;19:3753
70. Jacobs PA, Hunt PA, Matsuura JS, et al: Complete and hydatidiform mole in Hawaii: cytogenetics, morphology and epidemiology. Br J Obstet Gynaecol 1982;89:258-266
71. Paradinas FJ, Fisher RA, Browne P, et al: Diploid hydatidiform moles with fetal red blood cells in molar villi: 1. Pathology, incidence and prognosis. J Pathol 1997;181: 183-188
72. Braunstein GD, Vaitukaitis JL, Carbone PP, et al: Ectopic production of human chorionic gonadotrophin by neoplasms. Ann Intern Med 1973;78:39-45
73. Bagshawe KD: Risk and prognostic factors in trophoblastic neoplasia. Cancer 1976;38:1373-1385
74. Lawler SD, Klouda PT, Bagshawe KD: The relationship between HLA antibodies and the causal pregnancy in choriocarcinoma. Br J Obstet Gynaecol 1976;83:651-655
75. World Health Organization Scientific Group: Gestational Trophoblastic Disease. Geneva, World Health Organisation Technical Report ser 692. Geneva, WHO, 1983
76. Fisher RA, Paradinas FJ, Newlands ES, et al: Genetic evidence that placental site trophoblastic tumours can originate from a hydatidiform mole or a normal conceptus. Br J Cancer 1992;65:355-358
77. Fisher RA, Lawler SD, Povey S, et al: Genetically homozygous choriocarcinoma following pregnancy with hydatidiform mole. Br J Cancer 1988;58:788-792
78. Fisher RA, Newlands ES, Jeffreys AJ, et al: Gestational and non-gestational trophoblastic tumours distinguished by DNA analysis. Cancer 1992;69:839-845
79. Azuma C, Saji F, Nobunaga T, et al: Studies of the pathogenesis of choriocarcinoma by analysis of restriction fragment length polymorphisms. Cancer Res 1990;50:488-491
80. Osada H, Kawata M, Yamada M, et al: Genetic identification of pregnancies responsible for choriocarcinomas after multiple pregnancies by restriction fragment length polymorphism analysis. Am J Obstet Gynecol 1991;165:682-688
81. Arima T, Imamura T, Amada S, et al: Genetic origin of malignant trophoblastic neoplasms. Cancer Genet Cytogenet 1994;73:95-102
82. Suzuki T, Goto S, Nawa A, et al: Identification of the pregnancy responsible for gestational trophoblastic disease by DNA analysis. Obstet Gynecol 1993;82:629-634
83. Arima T, Imamura T, Sakuragi N, et al: Malignant trophoblastic neoplasms with different modes of origin. Cancer Genet Cytogenet 1995;85:5-15
84. Roberts DJ, Mutter GL: Advances in the molecular biology of gestational trophoblastic disease. J Reprod Med 1994;39: 201-208
85. Lorigan PC, Grierson AJ, Goepel RE, et al: Gestational choriocarcinoma of the ovary diagnosed by analysis of tumour DNA. Cancer Lett 1996;104:27-30
86. Bower M, Brock C, Fisher RA, et al: Gestational choriocarcinoma. Ann Oncol 1995;6:503-508
87. Bower M, Paradinas FJ, Fisher RA, et al: Placental site trophoblastic tumour: Molecular analysis and clinical experience. Clin Cancer Res 1996;2:897-902
88. MRC Human Genome Mapping Project Data Base/Medical Resources Council, Human Genome Mapping Project, Resource Centre (available from internet)
89. Parrington JM, West LF, Povey S: The origin of ovarian teratomas. J Med Genet 1984;21:4-12
90. Vejerslev LO, Fisher RA, Surti U, et al: Hydatidiform mole: Cytogenetically unusual cases and their implications for the present classification. Am J Obstet Gynecol 1987;57: 180-184
91. Surani MAH, Barton SC, Norris ML: Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis. Nature 1984;308:548-550
92. Barton SC, Surani MAH, Norris ML: Role of maternal and paternal genomes in mouse development. Nature 1984;311: 374-376
93. Vejerslev LO, Dissing J, Hansen HE: Hydatidiform mole: Genetic markers in diploid abortuses with macroscopic villous enlargement. Cancer Genet Cytogenet 1987;26:143-155
94. Ko T-M, Hsieh C-Y, Ho H-N, et al: Restriction fragment length polymorphism analysis to study the genetic origin of hydatidiform mole. Am J Obstet Gynecol 1991;164:901-906
95. Vejerslev LO, Sunde L, Hansen BF, et al: Hydatidiform mole and fetus with normal karyotype: support of a separate entity. Obstet Gynecol 1991;77:868-874
96. Spence JE, Perciaccante RG, Greig GM, et al: Uniparental disomy as a mechanism for human genetic disease. Am J Hum Genet 1988;42:217-226
97. Kajii T: Androgenetic origin of hydatidiform moles: Its bearing on carcinogenesis. Gann Monogr Cancer Res 1980; 25:189-194
98. Davis JR, Surwit EA, Garay JP, et al: Sex assignment in gestational trophoblastic neoplasia. Am J Obstet Gynecol 1984; 48:722-725
99. Wake N, Fujino T, Hoshi S, et al: The propensity to malignancy of dispermic heterozygous moles. Placenta 1987;8: 319-326
100. Mutter GL, Pomponio RJ, Berkowitz RS, et al: Sex chromosome composition of complete hydatidiform moles: Relationship to metastasis. Am J Obstet Gynecol 1993;168: 1547-1551
101. Henry I, Bonaiti-Pellie C, Chehensse V, et al: Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature 1991;351:665-667
102. Surani MA: Genomic imprinting: Control of gene expression by epigenetic inheritance. Curr Opin Cell Biol 1994;6: 390-395
103. Hao Y, Crenshaw T, Moulton T, et al: Tumour-suppressor activity of H19 RNA. Nature 1993;365:764-767
104. Rachmilewitz J, Goshen R, Ariel I, et al: Parental imprinting of the human H19 gene. FEBS lett 1992;309:25-28
105. Mutter GL, Stewart CL, Chaponot ML, et al: Oppositely imprinted genes H19 and insulin-like growth factor 2 are co-expressed in human androgenetic trophoblast. Am J Hum Genet 1993;53:1096-1102
106. Ohlsson R, Nystrom A, Pfeifer-Ohlsson S, et al: IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome. Nature Genet 1993;4: 94-97
107. Ariel I, Lustig O, Oyer CE, et al: Relaxation of imprinting in trophoblastic disease. Gynecol Oncol 1994;53:211-219
108. Walsh C, Miller SJ, Flam F, et al: Paternally-derived H19 is differentially expressed in malignant and non-malignant trophoblast. Cancer Res 1995;55:1111-1116
109. Arima T, Matsuda T, Takagi N, et al: Association of IGF2 and H19 imprinting with choriocarcinoma development. Cancer Genet Cytogenet 1997;93:39-47
110. Hashimoto K, Azuma C, Koyama M, et al: Loss of imprinting in choriocarcinoma. Nature Genet 1995;9:109-110
111. Rainier S, Johnson LA, Dobry CJ, et al: Relaxation of imprinted genes in human cancer. Nature 1993;362:747-749
112. Ogawa O, Eccles MR, Szeto J, et al: Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 1993;362:749-751
113. Mueller UW, Hawes CS, Wright AE, et al: Isolation of fetal trophobiast cells from peripheral blood of pregnant women. Lancet 1990;336:197-200
114. Martin DA, Sutton GP, Ulbright TM, et al: DNA content as a prognostic index in gestational trophoblastic neoplasia. Gynecol Oncol 1989;34:383-388
115. Lage JM, Mark SD, Roberts DJ, et al: A flow cytometric study of 137 fresh hydropic placentas: Correlation between types of hydatidiform moles and nuclear DNA ploidy. Obstet Gynecol 1992;79:403-410
116. Hemming JD, Quirke P, Womack C, et al: Flow cytometry in persistent trophoblastic disease. Placenta 1988;9:615-621
117. Bagshawe KD, Rawlins G, Pike MC, et al: ABO blood-groups in trophoblastic neoplasia. Lancet 1971;1:553-557
118. Bagshawe KD: Some facets of trophoblastic neoplasia in man. J Reprod Fertil (suppl) 1982;31:175-179
119. Lawler SD, Fisher RA: Immunogenicity of hydatidiform moles. Placenta 1987;8:195-199
120. Fisher RA, Johnson PH, Povey S, et al: ABO genotyping of complete hydatidiform moles. Dis Markers 1993;11:179-185
121. Cheung ANY, Srivastava G, Pittaluga S, et al: Expression of c-myc and c-forms oncogenes in trophoblastic cells in hydatidiform mole and normal human placenta. J Clin Pathol 1993;46:204-207
122. Greenblatt MS, Bennett WP, Hollstein M, et al: Mutations in the p53 tumour suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54:4855-4858
123. Cheung AN, Srivastava G, Chung LP, et al: Expression of the p53 gene in trophoblastic cells in hydatidiform moles and normal human placentas. J Reprod Med 1994;39: 223-227
124. Shi Y-F, Xie X, Zhao C-L, et al: Lack of mutation in tumour suppressor gene p53 in gestational trophoblastic tumours. Br J Cancer 1996;73:1216-1219
125. Dean M, Lucas-Derse S, Bolos A, et al: Genetic mapping of the β1 GABA receptor gene to human chromosome 4, using a tetranucleotide repeat polymorphism. Am J Obstet Gynecol 1991;49:621-626